600216 浙江医药
2024/03 - 三个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额23,171634,311520,6031,136,6561,256,722
投资活动产生之现金流量净额57,776(518,591)(971,154)(983,693)(237,723)
筹资活动产生之现金流量净额43,276(141,430)43,91469,754(627,474)
汇率变动对现金及现金等价物的影响4547,64076,015(79,839)(42,702)
现金及现金等价物净增加/(减少)124,26821,930(330,622)142,878348,824
期初现金及现金等价物余额1,459,8401,437,9091,768,5321,625,6541,276,830
期末现金及现金等价物余额1,584,1071,459,8401,437,9091,768,5321,625,654